Trial site
Pratia S.A.
- 10running trials
- 13closed trials
The trials here
What the 23 trials at this site are about, from their registry records.
- Conditions
- Diffuse large B-cell lymphoma4 trials
- Lung cancer4 trials
- Chronic lymphocytic leukaemia3 trials
- Hodgkin lymphoma3 trials
- Ulcerative colitis3 trials
- Alopecia areata1 trial
- Asthma1 trial
- Follicular lymphoma1 trial
- Gastric and oesophageal cancer1 trial
- Head and neck cancer1 trial
- Metastatic breast cancer1 trial
- Myeloproliferative neoplasms1 trial
- and 2 more
- Phase
- Phase 312 trials
- Phase 24 trials
- Phase 2/34 trials
- Phase 13 trials
- Status
- Completed13 trials
- Active, not recruiting8 trials
- Recruiting2 trials
- Lead sponsor
- Amgen Inc.3 trials
- Janssen Research & Development, LLC3 trials
- AstraZeneca2 trials
- Genmab2 trials
- Alvotech Swiss AG1 trial
- and 12 more
Running trials
Recruiting
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer2 recruiting
Closed trials
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
A Study of the MALT1 Inhibitor JNJ-67856633 and Ibrutinib in Combination in B-cell NHL and CLL
Completed
Completed
Active, not recruiting
Active, not recruiting
Brentuximab Vedotin Plus Lenalidomide and Rituximab for the Treatment of Relapsed/Refractory DLBCL
Completed
A Study of JNJ-64264681 in Participants With Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia
Site data: EU CTIS (euclinicaltrials.eu)Updated 13 Nov 2026